Christopher V.

Christopher V. has a diverse range of work experience in the legal field. Christopher currently serves as the Senior Transactional Counsel at Encoded Therapeutics Inc., a biotechnology company focused on genetic disorders. In this role, Christopher contributes to the advancement of precision medicines and focuses on viral gene therapy through genomics-driven discovery.

Prior to their current position, Christopher worked as an Attorney at Axiom, specializing in life sciences. Christopher provided legal advice to a variety of clients, including Fortune 500 medical device companies and biotech startups. Christopher'sresponsibilities included global acquisition due diligence and commercial contract negotiation.

Christopher also held management positions during their time at Weill Cornell Medicine and NYU Langone Health. At Weill Cornell Medicine, they were the Manager of Industry Agreements and Subawards, leading a team responsible for negotiating contracts with industry partners and federal agencies. At NYU Langone Health, they served as a Sr. Specialist, drafting and negotiating healthcare contracts and providing legal advice to doctors and hospital staff.

In addition to their corporate experience, Christopher gained legal clerkship experience at ConvergEx Group and NCR Corporation. Christopher also interned at the Legal Aid Society and worked as a Public Education Associate at the ACLU of Delaware.

Overall, Christopher V. has a strong background in transactional law, contract negotiation, and legal advisory services.

Christopher V.'s education history includes attending The Tatnall School, although it is unclear if they obtained a degree. Christopher went on to complete their Bachelor of Arts (B.A.) degree at the University of Delaware. Christopher V. then pursued further education at Brooklyn Law School, where they earned their Doctor of Law (J.D.) degree.